Kristen Pappas serves as Vice President, Clinical Operations at Hemab. She brings over 20 years of clinical operations experience in the pharmaceutical/biotechnologyindustry. Kristen began her career as a CRA at PRA Int’l and continued working in clinical operations at Wyeth/Genetics Institute, Acceleron Pharma, Biogen, and bluebird bio where she served as Senior Director in the Clinical Trial Strategy and Execution Department. Her work has spanned a broad range of therapeutic areas including diabetes, bone repair, hemophilia, thalassemia, oncology and adrenoleukodystrophy (ALD). She has participated in multiple EMA/FDA filings and inspections and was a key contributor to the approval of SkysonaTM for boys with ALD. Kristen holds a bachelor’s degree in biology from Union College and earned her MBA from Babson College.